HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick Micke Selected Research

Thyroid Nuclear Factor 1

1/2019Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
10/2018Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.
10/2016Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
11/2014Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick Micke Research Topics

Disease

69Neoplasms (Cancer)
11/2021 - 01/2003
31Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 10/2007
21Lung Neoplasms (Lung Cancer)
11/2021 - 01/2009
15Adenocarcinoma
01/2020 - 09/2004
9Neoplasm Metastasis (Metastasis)
01/2020 - 01/2003
8Adenocarcinoma of Lung
01/2022 - 09/2014
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 11/2011
5Breast Neoplasms (Breast Cancer)
01/2019 - 07/2009
4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2010
3Periodontitis
10/2021 - 01/2016
3Testicular Neoplasms (Testicular Cancer)
01/2019 - 01/2016
3Carcinoma (Carcinomatosis)
11/2018 - 08/2004
2COVID-19
12/2021 - 01/2020
2Carcinogenesis
10/2020 - 11/2018
2Large Cell Carcinoma
01/2019 - 11/2014
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2018 - 01/2003
2Weight Loss (Weight Reduction)
05/2017 - 01/2003
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2022
1Inflammation (Inflammations)
12/2021
1Cardiovascular Diseases (Cardiovascular Disease)
12/2021
1Insulinoma
01/2020
1Primary Myelofibrosis (Myelosclerosis)
01/2020
1Disease Progression
01/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020
1Malignant Mesothelioma
10/2019
1Chromosomal Instability (Chromosome Stability)
10/2019
1Lung Diseases (Lung Disease)
07/2019

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2007
14Biomarkers (Surrogate Marker)IBA
07/2020 - 12/2009
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2009
8LigandsIBA
01/2021 - 01/2003
7Messenger RNA (mRNA)IBA
01/2022 - 11/2011
6RNA (Ribonucleic Acid)IBA
01/2021 - 05/2012
5Phosphotransferases (Kinase)IBA
01/2021 - 01/2015
5Immunoglobulins (Immunoglobulin)IBA
01/2019 - 05/2012
5ParaffinIBA
10/2017 - 01/2009
4Pharmaceutical PreparationsIBA
01/2021 - 04/2010
4Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2020 - 04/2004
4Thyroid Nuclear Factor 1IBA
01/2019 - 11/2014
4AntigensIBA
01/2019 - 12/2003
4AntibodiesIBA
11/2018 - 01/2009
3CollagenIBA
10/2021 - 01/2016
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 - 01/2003
3Formaldehyde (Formol)FDA Link
11/2015 - 12/2010
3ErbB Receptors (EGF Receptor)IBA
07/2015 - 12/2010
2Blood Proteins (Serum Proteins)IBA
12/2021 - 07/2019
2Transcription Factors (Transcription Factor)IBA
11/2021 - 01/2016
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2021 - 04/2010
2B7-H1 AntigenIBA
01/2021 - 01/2019
2Scavenger Receptors (Scavenger Receptor)IBA
01/2021 - 10/2018
2ChemokinesIBA
10/2020 - 03/2009
2Tyrosine Kinase InhibitorsIBA
01/2020 - 04/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 03/2009
2MucinsIBA
01/2019 - 01/2019
2Complement System Proteins (Complement)IBA
01/2019 - 10/2017
2Keratin-5 (Keratin 5)IBA
01/2019 - 10/2016
2AutoantibodiesIBA
11/2018 - 12/2003
2tyrosine receptor (receptor, tyrosine)IBA
11/2018 - 01/2015
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2018 - 01/2015
2Estrogen ReceptorsIBA
01/2016 - 07/2009
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
07/2009 - 04/2004
2Platelet-Derived Growth FactorIBA
07/2009 - 04/2004
2Stem Cell FactorIBA
09/2004 - 01/2003
1ProteomeIBA
12/2021
1Neutralizing AntibodiesIBA
10/2021
1Keratins (Keratin)IBA
06/2021
1Thioredoxin Reductase 1IBA
06/2021
1Immune Checkpoint InhibitorsIBA
06/2021
1entrectinibIBA
01/2021
1larotrectinibIBA
01/2021
1TropomyosinIBA
01/2021
1CytokinesIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2021
1CyclinsIBA
10/2020
1Chromogranin AIBA
01/2020
1Therapeutic UsesIBA
01/2020
1Cell Surface ReceptorsIBA
01/2020
1Protein Tyrosine PhosphatasesIBA
01/2020
1SynaptophysinIBA
01/2020
1Etoposide (VP 16)FDA LinkGeneric
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2020
1PlatinumIBA
01/2020
1Immune Checkpoint ProteinsIBA
01/2020
1AmylasesFDA Link
01/2019
1Periodic AcidIBA
01/2019
1Alcian BlueIBA
01/2019
1mucicarmineIBA
01/2019
1Keratin-7 (Cytokeratin 7)IBA
01/2019
1LipidsIBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2018

Therapy/Procedure

23Therapeutics
01/2022 - 08/2004
6Immunotherapy
01/2022 - 01/2016
4Drug Therapy (Chemotherapy)
01/2020 - 01/2003
3Radiotherapy
01/2022 - 12/2016
3Precision Medicine
10/2017 - 06/2012
3Lasers (Laser)
06/2009 - 08/2004
2Isogeneic Transplantation
11/2021 - 10/2020
1Segmental Mastectomy (Lumpectomy)
01/2022
1Ligation
01/2020